PATH-09. SJMB12 CLINICAL TRIAL: DISCREPANCY BETWEEN LOCAL AND CENTRAL PATHOLOGY IN ASSESSING ANAPLASTIC MEDULLOBLASTOMA – REPORT FROM A SINGLE SITE EXPERIENCE

INTRODUCTION: SJMB12 is a phase 2 clinical trial led by the St. Jude Children’s Research Hospital (St. Jude) that enrolls patients with medulloblastoma based on their biological subgroup. The large cell/anaplastic (LCA) histologic variant has been identified as an important independent risk factor a...

Descripción completa

Detalles Bibliográficos
Autores principales: Khuong-Quang, Dong-Anh, Williamson, Karli, MacGregor, Duncan, Orr, Brent A, Gajjar, Amar, Robinson, Giles W, Sullivan, Michael J, Hansford, Jordan R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Pathology and Molecular Diagnosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715382/
http://dx.doi.org/10.1093/neuonc/noaa222.645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715382/
http://dx.doi.org/10.1093/neuonc/noaa222.645

Ejemplares similares